140 related articles for article (PubMed ID: 7510699)
1. Cytosolic Ca2+ transients are not required for platelet-derived growth factor to induce cell cycle progression of vascular smooth muscle cells in primary culture. Actions of tyrosine kinase.
Kobayashi S; Nishimura J; Kanaide H
J Biol Chem; 1994 Mar; 269(12):9011-8. PubMed ID: 7510699
[TBL] [Abstract][Full Text] [Related]
2. Platelet derived growth factor induces c-fos and c-myc mRNA in rat aortic smooth muscle cells in primary culture without elevation of intracellular Ca2+ concentration.
Nishimura J; Kobayashi S; Shikasho T; Kanaide H
Biochem Biophys Res Commun; 1992 Nov; 188(3):1198-204. PubMed ID: 1445353
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine kinase signaling pathways modulate angiotensin II-induced calcium ([Ca2+]i) transients in vascular smooth muscle cells.
Touyz RM; Schiffrin EL
Hypertension; 1996 May; 27(5):1097-103. PubMed ID: 8621202
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine kinase inhibitors inhibit multiple steps of the cell cycle of vascular smooth muscle cells.
Shimokado K; Umezawa K; Ogata J
Exp Cell Res; 1995 Oct; 220(2):266-73. PubMed ID: 7556433
[TBL] [Abstract][Full Text] [Related]
5. Genistein sensitivity of calcium transport pathways in serotonin-activated vascular smooth muscle cells.
Nelson SR; Chien T; Di Salvo J
Arch Biochem Biophys; 1997 Sep; 345(1):65-72. PubMed ID: 9281312
[TBL] [Abstract][Full Text] [Related]
6. Endothelin-1 and angiotensin II act as progression but not competence growth factors in vascular smooth muscle cells.
Jahan H; Kobayashi S; Nishimura J; Kanaide H
Eur J Pharmacol; 1996 Jan; 295(2-3):261-9. PubMed ID: 8720593
[TBL] [Abstract][Full Text] [Related]
7. Receptor-activated increases in intracellular calcium and protein tyrosine phosphorylation in vascular smooth muscle cells.
Semenchuk LA; Di Salvo J
FEBS Lett; 1995 Aug; 370(1-2):127-30. PubMed ID: 7544299
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of Ca2+ channel blockers on Ca2+ transients and cell cycle progression in vascular smooth muscle cells.
Ahmed A; Kobayashi S; Shikasho T; Nishimura J; Kanaide H
Eur J Pharmacol; 1998 Mar; 344(2-3):323-31. PubMed ID: 9600669
[TBL] [Abstract][Full Text] [Related]
9. Growth factors mediate intracellular signaling in vascular smooth muscle cells through protein kinase C-linked pathways.
Touyz RM; Schiffrin EL
Hypertension; 1997 Dec; 30(6):1440-7. PubMed ID: 9403565
[TBL] [Abstract][Full Text] [Related]
10. Platelet-derived growth factor and angiotensin II cause increases in cytosolic free calcium by different mechanisms in vascular smooth muscle cells.
Roe MW; Hepler JR; Harden TK; Herman B
J Cell Physiol; 1989 Apr; 139(1):100-8. PubMed ID: 2708448
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of endothelin-1-induced calcium response by tyrosine kinase inhibitors in vascular smooth muscle cells.
Liu CY; Sturek M
Am J Physiol; 1996 Jun; 270(6 Pt 1):C1825-33. PubMed ID: 8764168
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of lovastatin on mitogen induced calcium influx in human cultured vascular smooth muscle cells.
Clunn GF; Lymn JS; Schachter M; Hughes AD
Br J Pharmacol; 1997 Aug; 121(8):1789-95. PubMed ID: 9283719
[TBL] [Abstract][Full Text] [Related]
13. P2U purinergic activation leads to the cell cycle progression from the G1 to the S and M phases but not from the G0 to G1 phase in vascular smooth muscle cells in primary culture.
Miyagi Y; Kobayashi S; Ahmed A; Nishimura J; Fukui M; Kanaide H
Biochem Biophys Res Commun; 1996 May; 222(2):652-8. PubMed ID: 8670259
[TBL] [Abstract][Full Text] [Related]
14. Coupling between [arginine8]-vasopressin-activated increases in protein tyrosine phosphorylation and cellular calcium in A7r5 aortic smooth muscle cells.
Kaplan N; Di Salvo J
Arch Biochem Biophys; 1996 Feb; 326(2):271-80. PubMed ID: 8611034
[TBL] [Abstract][Full Text] [Related]
15. Regulation of a calcium-dependent tyrosine kinase in vascular smooth muscle cells by angiotensin II and platelet-derived growth factor. Dependence on calcium and the actin cytoskeleton.
Brinson AE; Harding T; Diliberto PA; He Y; Li X; Hunter D; Herman B; Earp HS; Graves LM
J Biol Chem; 1998 Jan; 273(3):1711-8. PubMed ID: 9430717
[TBL] [Abstract][Full Text] [Related]
16. High D-glucose stimulates the cell cycle from the G1 to the S and M phases, but has no competent effect on the G0 phase, in vascular smooth muscle cells.
Hiroishi G; Kobayashi S; Nishimura J; Inomata H; Kanaide H
Biochem Biophys Res Commun; 1995 Jun; 211(2):619-26. PubMed ID: 7540840
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of bradykinin- and thapsigargin-induced Ca2+ entry by tyrosine kinase inhibitors.
Lee KM; Toscas K; Villereal ML
J Biol Chem; 1993 May; 268(14):9945-8. PubMed ID: 7683685
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II regulates vascular smooth muscle cell pH, contraction, and growth via tyrosine kinase-dependent signaling pathways.
Touyz RM; Schiffrin EL
Hypertension; 1997 Aug; 30(2 Pt 1):222-9. PubMed ID: 9260984
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine phosphorylation and [Ca2+]i elevation induced by hemolysate in bovine endothelial cells: implications for cerebral vasospasm.
Marton LS; Weir BK; Zhang H
Neurol Res; 1996 Aug; 18(4):349-53. PubMed ID: 8875455
[TBL] [Abstract][Full Text] [Related]
20. Serotonin stimulates protein tyrosyl phosphorylation and vascular contraction via tyrosine kinase.
Watts SW; Yeum CH; Campbell G; Webb RC
J Vasc Res; 1996; 33(4):288-98. PubMed ID: 8695753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
